Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had revenue of $58.56M in the quarter ending September 30, 2024, with 12,385.07% growth. This brings the company's revenue in the last twelve months to $90.86M, up 12,751.20% year-over-year. In the year 2023, Iovance Biotherapeutics had annual revenue of $1.19M.

• Revenue (ttm): $90.86M
• Revenue Growth: +12,751.20%
• P/S Ratio: 22.55
• Revenue / Employee: $163,120
• Employees: 557
• Market Cap: 2.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.